AXA S.A. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 85 filers reported holding OVID THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 6.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
AXA S.A. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,433,000
-58.0%
620,402
+4.3%
0.00%
-66.7%
Q3 2020$3,413,000
-67.4%
594,667
-58.1%
0.01%
-42.9%
Q2 2020$10,464,000
+115.1%
1,419,900
-13.0%
0.02%
+75.0%
Q1 2020$4,864,000
-32.5%
1,632,144
-5.9%
0.01%
-20.0%
Q4 2019$7,202,0001,735,2040.02%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders